SEC Form 4 · accession 0001179110-15-012363
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2015 | S | 312 | $21.67 | D | 99,068 | D | |
| Common StockF3 | Aug 18, 2015 | S | 2,840 | $21.80 | D | 96,228 | D | |
| Common Stock | Aug 18, 2015 | S | 76 | $22.00 | D | 96,152 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9 2009.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
- F3This transaction was executed in multiple trades at prices ranging from $21.70 to $22.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.